HEALTHCARE (XLV)
150.41
+3.13 (2.13%)
NYSE · Last Trade: Nov 11th, 1:20 PM EST
Detailed Quote
| Previous Close | 147.28 |
|---|---|
| Open | 147.60 |
| Day's Range | 147.60 - 150.44 |
| 52 Week Range | 127.35 - 150.60 |
| Volume | 6,784,935 |
| Market Cap | 371.54M |
| Dividend & Yield | 2.500 (1.66%) |
| 1 Month Average Volume | 10,462,693 |
Chart
News & Press Releases
U.S. equities took a breather on Tuesday, stabilizing after Monday's sharp rally as investors awaited a House vote on the temporary spending bill expected to end the record-long government shutdown later this week.
Via Benzinga · November 11, 2025
Pfizer CEO Reportedly Drops F-Bomb On Live TV Discussing Seagen, Metsera Dealsstocktwits.com
Via Stocktwits · November 10, 2025
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.
Via Benzinga · November 10, 2025
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technology stocks toward their worst week since April.
Via Benzinga · November 7, 2025
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Via Benzinga · November 6, 2025
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.
Via Benzinga · November 5, 2025
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date rallies.
Via Benzinga · November 4, 2025
Wall Street opened the week on a mixed note on Monday.
Via Benzinga · November 3, 2025
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
Via Benzinga · October 30, 2025
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
Via Benzinga · October 31, 2025
As markets enter their strongest stretch, ETFs tied to AI, banking, and healthcare could shine. Here's where investors are finding fresh momentum.
Via Benzinga · October 30, 2025
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Via Benzinga · October 30, 2025
CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain.
Via Stocktwits · October 30, 2025
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
Via Benzinga · October 28, 2025
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's
Via Benzinga · October 29, 2025
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech earnings.
Via Benzinga · October 28, 2025
Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023.
Via Stocktwits · October 28, 2025